Previous Close | 12.69 |
Open | 12.53 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 11.65 - 13.03 |
52 Week Range | 4.60 - 18.26 |
Volume | 255,830 |
Avg. Volume | 354,826 |
Market Cap | 74.422M |
Beta (5Y Monthly) | 1.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -7.39 |
Earnings Date | Mar 11, 2021 - Mar 15, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 45.20 |
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / February 24, 2021/ Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that three posters featuring data on smoker and e-cigarette user behavior will be presented today, Wednesday, February 24th at the SRNT Annual Meeting being held virtually.
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / February 11, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will present at the MicroCap Rodeo Winter Wonderland Conference, which is being held virtually on February 16th \- 19th, 2021.
Disposition of Securities of Docebo Inc./NOT FOR DISTRIBUTION TO UNITED STATES OF AMERICA WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OF AMERICA/TORONTO, Jan.